Frank Stonebanks

Director

Frank has twenty-five years of global executive operational (from sales to 3 time CEO, 2 time Founder) and investment experience in biotech, pharma, med tech, drug delivery and health technology, including executive management, fund formation/capital raising, deal structuring/execution, negotiating, domestic & global marketing, L&A, finance, sales, venture capital investing & senior advisory, covering small start-ups, mid-size public companies, large Fortune 50 companies, universities, not for profits, domestic, international and public sector entities.

  • Current: Wavemaker 360 Health Special Advisor
  • Former:
    • Founder / CEO / General Partner at Triphase LP (lead asset acquired in 2016 by Celgene (BMS)
    • Founder / CEO at Zosano Pharma (ZSAN: NASDAQ) spun out from J&J
    • Senior Advisor, NovaQuest Capital Management
    • Venture Partner, Lumira Ventures
    • CBO, Head of Investment Fund, Ontario Institute for Cancer Research
    • Senior Advisor / Fund of Funds Co-Manager, IBM, Healthcare M&A Head
    • VP Investments / GM, J&J (Johnson & Johnson investment arm, JJDC)
    • Head of Licensing, NABI Biopharmaceuticals
    • Global Product Manager, Sanofi
Back to Home